Mobosetinib succinate capsule dosage price domestic selling price

Mobosetinib succinate capsule, as a highly selective targeted drug, specifically inhibits EGFRexon20 tyrosine kinase insertion mutations. This innovative medicine brings hope to adult patients with locally advanced or metastatic non-small cell lung cancer diagnosed with an EGFRexon20 insertion mutation through an FDA-approved test. Especially for patients whose disease progresses during or after platinum-based chemotherapy, moboxetinib is undoubtedly an important new treatment option.

However, although moboxetinib has been successfully marketed in China, it has not yet been covered by my country's medical insurance system. This means that patients must pay the full cost of the drug when they need it. Currently on the market, the price of 40mg112 mobosetinib capsules is as high as 40,000 to 50,000 yuan. However, at the same time, the price of mobosetinib in overseas markets is relatively affordable. For example, the price of Japan's original version of 40 mg 30 tablets is about 8,000 yuan, which has a significant price advantage compared with the domestic version. In Bangladesh and Laos, generic versions of mobotinib are already on the market. The ingredients of these generic drugs are basically the same as those of the original drugs, but the price is more affordable. The latest price is only about 4,000 yuan.

Patients can choose the most appropriate purchase method based on their financial status and treatment needs. But no matter which version of the drug you choose, you must ensure the formality of its source to ensure the quality and safety of the drug.